Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.

@article{Capone2018ComparisonOT,
  title={Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA.},
  author={Domenico Capone and Mauro Cataldi and Bruna Guida and Teresa Mosca and Giovanni Tarantino},
  journal={Scandinavian journal of clinical and laboratory investigation},
  year={2018},
  volume={78 4},
  pages={
          275-280
        }
}
Few years ago, it was proposed that everolimus blood levels could be determined with the commercially available sirolimus chemiluminescence magnetic microparticle immunoassay (CMIA). More recently, a highly specific microsphere system (QMS) has been approved by FDA for therapeutic drug monitoring in humans. Aim of the present study was to compare the… CONTINUE READING